Complete Response Letters

AB Pharmaceuticals, LLC: NDA 210649

What FDA's Complete Response Letters to the company say, in the letters' own words.

EphemerisX Research · Sep 30, 2026 · Sources: FDA, SEC

Complete Response Letter, Sep 12, 2018

Relief (PEPFAR) program until you have been notified in writing that this application is approved.

Complete Response Letter · Sep 12, 2018 · p. 3Open the letter at p. 3 ↗CRL_NDA210649_20180912:p1:s45

Relief (PEPFAR) program until you have been notified in writing that the application is tentatively approved.

Complete Response Letter · Mar 13, 2018 · p. 6Open the letter at p. 6 ↗CRL_NDA210649_20180313:p1:s43

Updated Sep 30, 2026 · built from 283 companies in the EphemerisX knowledge graph. This page is regenerated as companies are added.